ALZN
ALZAMEND (ALZN)
NASDAQ
$1.15+$0.01 (+1.23%)
Price as of Jun 03, 2026 7:52 PM EDT
  • $4.5M
    Market Cap
  • -70.23%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
04/30/2025
04/30/2024
04/30/2023
04/30/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
-100.00%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.4M
-78.08%
-6.5M
-13.31%
-7.4M
+43.15%
-5.2M
+296.83%
Depreciation and Amortization Expense
50,740
0.00%
50,740
+119.98%
23,066
+549.93%
3,549
N/A
Total Operating Expenses
4.5M
-54.75%
9.9M
-33.17%
14.9M
+20.71%
12.3M
+148.78%
Operating Profit
-4.5M
-54.75%
-9.9M
-33.17%
-14.9M
+20.71%
-12.3M
+148.78%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-18,029
+78.49%
-10,101
+31.16%
-7,701
-83.45%
-46,524
-67.33%
Interest Income and Expense and Net
-18,029
+78.49%
-10,101
+31.16%
-7,701
-83.45%
-46,524
-67.33%
Total Nonoperating Income and Expense
-18,029
+78.49%
-10,101
+31.16%
-7,701
-81.89%
-42,524
-55.09%
Income before Taxes
-5.1M
-48.63%
-9.9M
-33.17%
-14.9M
+20.71%
-12.3M
+148.78%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-5.1M
-48.68%
-9.9M
-33.14%
-14.9M
+20.35%
-12.4M
+144.96%
Net Income from Continuing Operations Applicable to Common
-5.1M
-48.68%
-9.9M
-33.14%
-14.9M
+20.35%
-12.4M
+144.96%
Basic EPS and Net Income
-11.32
-22.99%
-14.70
+9,700.00%
-0.15
N/A
N/A
N/A
Diluted EPS and Net Income
-11.32
-22.99%
-14.70
+9,700.00%
-0.15
N/A
N/A
N/A
Basic Weighted Average Shares
450,799
-33.37%
676,565
-99.31%
97.5M
+9.45%
89.1M
+22.64%
Diluted Weighted Average Shares
450,799
-33.37%
676,565
-99.31%
97.5M
+9.45%
89.1M
+22.64%
Balance Sheet
Cash and Cash Equivalents
3.9M
+950.04%
376,048
-92.69%
5.1M
-63.45%
14.1M
+628.97%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
3.9M
+950.04%
376,048
-92.69%
5.1M
-63.45%
14.1M
+628.97%
Total Current Assets
4.2M
+817.62%
455,242
-92.20%
5.8M
-59.51%
14.4M
+394.87%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
425,606
+141.35%
176,346
+120.87%
79,843
-22.41%
102,909
N/A
Total Long-Term Assets
425,606
+141.35%
176,346
+120.87%
79,843
-22.41%
102,909
-70.81%
Total Assets
4.6M
+628.80%
631,588
-89.32%
5.9M
-59.25%
14.5M
+398.40%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
300,714
N/A
N/A
N/A
2,082
-96.57%
Total Current Liabilities
634,761
-80.32%
3.2M
+12.39%
2.9M
+146.38%
1.2M
+29.49%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
634,761
-80.32%
3.2M
+12.39%
2.9M
+146.38%
1.2M
+29.49%
Retained Earnings
-58.5M
+8.36%
-54.0M
+22.57%
-44.1M
+50.96%
-29.2M
+73.44%
Total Stockholders Equity
4.0M
+252.97%
-2.6M
-185.18%
3.0M
-77.19%
13.4M
+563.28%
Total Shares Outstanding
778,733
+13.19%
687,999
-99.29%
96.9M
+1.53%
95.5M
+41.60%
Cash Flow
Cash from Operating Activities
-6.6M
-20.58%
-8.3M
-7.32%
-8.9M
+34.91%
-6.6M
+143.88%
Capital Expenditures
300,000
+103.74%
147,243
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-300,000
+103.74%
-147,243
N/A
N/A
N/A
-106,458
-205.49%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
10.4M
+185.86%
3.7M
+1,826,112.50%
200
-100.00%
18.9M
+323.70%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-195.05%
-35.81%
-303.88%
+108.66%
-145.64%
+2.66%
-141.86%
N/A
Return on Equity
-743.08%
-83.14%
-4,408.31%
+2,329.17%
-181.47%
+12.77%
-160.92%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
6.58
+4,564.07%
0.14
-93.06%
2.03
-83.57%
12.37
N/A
Cash Ratio
6.22
+5,235.08%
0.12
-93.49%
1.79
-85.16%
12.07
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow